Track 4: Pharmacogenomics

Pharmacogenomics explores how genetic differences influence drug effectiveness, metabolism, toxicity, and individual treatment responses. Topics include genetic biomarkers, pharmacogenetic testing, SNP analysis, genomic sequencing, and genotype-guided therapy. Researchers can investigate how genetic information can support safer drug selection and individualized dosing. The track also covers applications in oncology, cardiovascular medicine, psychiatry, infectious diseases, and other therapeutic areas. Emerging technologies for integrating genomic information into routine clinical decision-making are highlighted. Research supporting more precise, effective, and patient-specific pharmaceutical treatments is particularly encouraged.

 

    Related Conference of Track 4: Pharmacogenomics

    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    February 15-16, 2027

    23rd Annual Congress on Pharmacology and Toxicology

    Paris, France
    February 22-23, 2027

    41st World Congress on Pharmacology and Therapeutics

    Amsterdam, Netherlands
    April 08-09, 2027

    21st World Drug Delivery Summit

    Vienna, Austria
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France
    April 27-28, 2027

    19th World Drug Delivery Summit

    Paris, France

    Track 4: Pharmacogenomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in